Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort

Author:

Tosun Duygu1,Chen Yun-Fei2,Yu Peng2,Sundell Karen L.2,Suhy Joyce3,Siemers Eric2,Schwarz Adam J.2,Weiner Michael W.1,

Affiliation:

1. Department Radiology and Biomedical Imaging University of California—San Francisco San Francisco CA USA

2. Eli Lilly and Company Indianapolis IN USA

3. BioClinica CA USA

Funder

National Institutes of Health

Alzheimer's Disease Neuroimaging Initiative

U.S. Department of Defense

National Institute on Aging

National Institute of Biomedical Imaging and Bioengineering

AbbVie

Alzheimer's Association

Alzheimer's Drug Discovery Foundation

BioClinica

Biogen

Bristol-Myers Squibb

Eisai

Eli Lilly and Company

F. Hoffmann-La Roche

Genentech

Fujirebio Europe

GE Healthcare

Lundbeckfonden

Merck

Meso Scale Diagnostics

Novartis Pharmaceuticals Corporation

Pfizer

Servier

Takeda Pharmaceutical Company

Canadian Institutes of Health Research

Foundation for the National Institutes of Health

Northern California Institute for Research and Education

NIH

Alzheimer's Disease Neuroimaging Initiative (ADNI)

DOD ADNI

Department of Defense

Araclon Biotech

BioClinica, Inc.

Bristol-Myers Squibb Company

CereSpir, Inc.

Eisai Inc.

Elan Pharmaceuticals, Inc.

EuroImmun

F. Hoffmann-La Roche Ltd

Genentech, Inc.

Fujirebio

IXICO Ltd.

Janssen Alzheimer Immunotherapy Research & Development, LLC.

Johnson & Johnson Pharmaceutical Research & Development LLC.

Lumosity

Lundbeck

Merck & Co., Inc.

Meso Scale Diagnostics, LLC.

NeuroRx Research

Neurotrack Technologies

Pfizer Inc.

Piramal Imaging

Transition Therapeutics

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3